Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus

Código QR

Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus

Jing Xie,1 Ning Li,1 Xiaoyan Jiang,1 Liyin Chai,1 Jian-Jun Chen,2 Wuquan Deng11Department of Endocrinology and Nephrology, Chongqing University Central Hospital, Chongqing Emergency Medical Center, Chongqing 400014, People’s Republic of China; 2Institute of Life Sciences, Chongqing Medical...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Xie J, Li N, Jiang X, Chai L, Chen JJ, Deng W
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	repaglinide glimepiride metformin diabetes meta-analysis Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/b013de3547b04ea7b3ef2088d0bb94ea
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
por: Moses R
Publicado: (2010)

Evaluation of fixed dose combination of glimepiride and metformin in patients with type 2 diabetes. Results of Russian observational study
por: Natalya Vladislavovna Zaytseva, et al.
Publicado: (2015)

Efficacy and safety of glimepiride as initial treatment in Russian patients with type 2 diabetes mellitus
por: Alexander Sergeevich Ametov, et al.
Publicado: (2013)

Modern antihyperglycemic therapy: safety and efficacy of glimepiride
por: Lyudmila Alexandrovna Ruyatkina, et al.
Publicado: (2012)

DEVELOPMENT AND VALIDATION OF HPTLC DENSITOMETRY METHOD FOR SIMULTANEOUS ESTIMATION OF ROSIGLITAZONE AND GLIMEPIRIDE IN FIXED TABLET DOSAGE FORM
por: DHOLE,SEEMA M, et al.
Publicado: (2013)

The Impact of Surfactant Composition and Surface Charge of Niosomes on the Oral Absorption of Repaglinide as a BCS II Model Drug
por: Yaghoobian M, et al.
Publicado: (2020)

Improved oral bioavailability of poorly water-soluble glimepiride by utilizing microemulsion technique
por: Li HY, et al.
Publicado: (2016)

Optimization of therapy of type 2 diabetes mellitus with the oral hypoglycemic agent glimepiride
por: Tatiana Ivanovna Romantsova, et al.
Publicado: (2010)

Mechanistic analysis of Zein nanoparticles/PLGA triblock in situ forming implants for glimepiride
por: Ahmed OAA, et al.
Publicado: (2016)

Fixed combination of repaglinide and metformin in the management of type 2 diabetes
por: Robert Moses
Publicado: (2009)

Fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro α-glucosidase inhibition
por: Rahim H, et al.
Publicado: (2019)

Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
por: Zhang Q, et al.
Publicado: (2020)

Fabrication and Characterization of Glimepiride Nanosuspension by Ultrasonication-Assisted Precipitation for Improvement of Oral Bioavailability and in vitro α-Glucosidase Inhibition [Corrigendum]
por: Rahim H, et al.
Publicado: (2020)

Influence of type-4 dipeptidyl peptidase inhibition on endothelium-dependent relaxation of aortae from a db/db mouse model of type 2 diabetes: a comparison with the effect of glimepiride
por: Woodman OL, et al.
Publicado: (2019)

Metformin Treatment: A Potential Cause of Megaloblastic Anemia in Patients with Type 2 Diabetes Mellitus
por: Albai O, et al.
Publicado: (2020)

Combination of Metformin and Exercise in Management of Metabolic Abnormalities Observed in Type 2 Diabetes Mellitus
por: Jevtovic F
Publicado: (2021)

Incidence and Survival of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Cirrhosis Who Were Treated with and without Metformin
por: Tangjarusritaratorn T, et al.
Publicado: (2021)

Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
por: Alexander Sergeevich Ametov, et al.
Publicado: (2010)

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
por: Robert G Moses
Publicado: (2010)

Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women
por: Leng W, et al.
Publicado: (2021)

Patient considerations in type 2 diabetes – role of combination dapagliflozin–metformin XR
por: Kuecker CM, et al.
Publicado: (2016)

Dissolution Profile Evaluation of Eight Brands of Metformin Hydrochloride Tablets Available in Jimma, Southwest Ethiopia
por: Umeta B, et al.
Publicado: (2021)

Sodium–glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin–metformin
por: Schwartz SS, et al.
Publicado: (2016)

Development and characterization of multiparticulate system as an alternative to unit dosage forms containing drugs with diverse release profiles
por: Vandana Dhanorkar, et al.
Publicado: (2021)

Low Branched Chain Amino Acids and Tyrosine in Thai Patients with Type 2 Diabetes Mellitus Treated with Metformin and Metformin-Sulfonylurea Combination Therapies
por: Natthida Sriboonvorakul, et al.
Publicado: (2021)

Inhibition of Diabetes Mellitus-Induced Knee Joint Injury in Rats by a Combination of Metformin and Captopril
por: El-Bidawy,Mahmoud H, et al.
Publicado: (2021)

A Comparison Between the Therapeutic Effect of Metformin Alone versus a Combination Therapy with Insulin in Uncontrolled, Non-Adherence Patients with Type 2 Diabetes: Six Months Follow-Up
por: Paczkowska A, et al.
Publicado: (2021)

Metformin Induces Ultrastructural Alterations in Hepatocytes of Spontaneously Hypertensive Rats
por: Gharbaran,Rajendra
Publicado: (2014)

Efficacy and safety of metformin for the treatment of gestational diabetes: a new approach to the problem
por: Anna I. Sazonova, et al.
Publicado: (2016)

Assessment of Serum Vitamin B12 and Folate Levels and Macrocytosis in Patients with Type 2 Diabetes Mellitus on Metformin Attending Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A Cross-Sectional Study
por: Wale Tesega W, et al.
Publicado: (2021)

Metformin-Insulin versus Metformin-Sulfonylurea Combination Therapies in Type 2 Diabetes: A Comparative Study of Glycemic Control and Risk of Cardiovascular Diseases in Addis Ababa, Ethiopia
por: Gebrie D, et al.
Publicado: (2021)

Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study
por: Hassoun AAK, et al.
Publicado: (2016)

Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus
por: Holl, et al.
Publicado: (2014)

Metformin and Malignant Tumors: Not Over the Hill
por: Leng W, et al.
Publicado: (2021)

Intronic Variants in OCT1 are Associated with All-Cause and Cardiovascular Mortality in Metformin Users with Type 2 Diabetes
por: Schweighofer N, et al.
Publicado: (2020)

MARCH: factors associated with weight loss in patients with newly diagnosed type 2 diabetes treated with acarbose or metformin
por: Na Wang, et al.
Publicado: (2019)

DEVELOPMENT, COMPUTATIONAL STUDIES AND VALIDATION OF SPECTROPHOTOMETRIC METHOD OF METFORMIN HYDROCHLORIDE IN PHARMACEUTICAL FORMULATIONS
por: Judeh,Ahmed Abu, et al.
Publicado: (2020)

Metformin Protects Against Thioacetamide Induced Liver injury in Rats
por: Al-Hashem,Fahaid, et al.
Publicado: (2018)

Metformin Pretreatment Ameliorates Diabetic Nephropathy Induced by a Combination of High Fat Diet and Streptozotocin in Rats
por: Dallak,Mohammad, et al.
Publicado: (2018)

Metformin and cancer mortality
por: Lev Mikhaylovich Bershteyn
Publicado: (2010)